Summary
The National Institute of Allergy and Infectious Diseases (NIAID) supports the MHC Tetramer Core facility, which synthesizes and distributes soluble MHC tetramer reagents to the global research community.
NIH Tetramer Core Facility (Influenza)
US · IL
National Institute of Allergy and Infectious Diseases (NIAID)
grant
awarded
#nih-75N93020D00005-P00006-759302000001-4
What they want
The facility supports research on the basic understanding of immune responses, leading to the development of vaccines and novel therapeutic agents for the prevention and treatment of influenza, and improvements in public health, by providing essential reagents.
Deliverables
- Synthesis of soluble MHC tetramer reagents
- Distribution of soluble MHC tetramer reagents
